Skip to main content

Part of the book series: Angewandte Onkologie ((AONKOLOGIE))

  • 25 Accesses

Zusammenfassung

Das Melanom ist der maligne Tumor der Melanozyten (Pigmentzellen) der Haut und der körpernahen Schleimhäute, in Ausnahmefällen auch anderer Organe (Auge, Meningen, Lymphknoten, etc.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Mackie RM,Young D (1984) Human malignant melanoma. IntJ Dermatol 23: 433

    CAS  Google Scholar 

  2. Kopf AW Kripke ML, Stern RS (1984) Sun and malignant melanoma.J Am Acad Dermatol 11: 674

    Article  Google Scholar 

  3. Reimer RR, Wallace HC Jr, Greene MH, et al (1978) Precursor lesions in familial melanoma. JAMA 239: 744

    Article  PubMed  CAS  Google Scholar 

  4. Kaplan EN (1974)The risk of malignancy in large congenital naevi. Plast Reconstr Surg 53:421

    Article  CAS  Google Scholar 

  5. Elder DE, Goldman LI, Goldman SC, et al (1980) The dysplastic naevus syndrome: a phenotypic association of melanoma. Cancer 46: 1787

    Article  PubMed  CAS  Google Scholar 

  6. Lynch HT, Fusaro RM, Peter J, et al (1981)Tumourspectrum in the FAMMM syndrome. Br J Cancer 44: 553

    Article  Google Scholar 

  7. Gromet MA, Epstein WL, Blois MS (1979)The regressing thin malignant melanoma—a distinctive lesion with metastatic potential. Cancer 42: 2282

    Article  Google Scholar 

  8. Lerman RI, Murray D, O’Hara JM, et al (1970) Malignant melanoma of childhood: a clinicopathologic study and a report of 12 cases. Cancer 25: 436

    Article  PubMed  CAS  Google Scholar 

  9. Rampen FHJ, Van der Esch EP (1985) Biopsy and survival of malignant melanoma. J Am Acad Dermatol 12: 385

    Article  PubMed  CAS  Google Scholar 

  10. Friedman RJ, Rigel DS, Kopf AW (1985) Early detection of malignant melanoma. The role of physician examination and self examination of the skin. Cancer 35: 4

    Google Scholar 

  11. Clark WH Jr, From L, Bernadino EA, et al (1969) The histogenesis and biologic behaviour of primary human malignant melanoma of the skin. Cancer Res 29: 705

    PubMed  Google Scholar 

  12. Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902

    Article  PubMed  CAS  Google Scholar 

  13. Garbe C, Stadler R, Orfanos CE (1986) Prognose-orientierte Therapie bei malignem Melanom. Hautarzt 37: 365

    PubMed  CAS  Google Scholar 

  14. Balch CM (1980) Surgical management of regional lymph nodes in cutaneous melanoma.) Am Acad Dermatol 3: 511

    CAS  Google Scholar 

  15. Martijn H, Oldhoff J, Oosterhuis JW, et al (1983) Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion. Cancer 52: 1526

    Article  PubMed  CAS  Google Scholar 

  16. Sim FH,Taylor WF, Ivins JC, et al (1978)A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 41: 948

    Article  Google Scholar 

  17. Veronesi U, Adamus J, Bandiera CC, et al (1972) Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 197: 627

    Google Scholar 

  18. Balch CM, Soong SJ, Milton GW, et al (1982) A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196: 677

    Google Scholar 

  19. McCarthy WH, Shaw HM, Milton GW (1985) Efficacy of selective lymph node dissection in 2347 patients with clinical stage I malignant melanoma. Surg Gynecol Ob-stet 161: 575

    CAS  Google Scholar 

  20. Munz DL, Altmeyer P, Holzmann H, et al (1982) Der Stellenwert der Lymphszintigraphie in der Behandlung maligner Melanome. Dtsch Med Wochenschr 107: 86

    Article  PubMed  CAS  Google Scholar 

  21. Veronesi MD, Adamus J, Aubert C, et al (1982)A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307: 913

    Article  PubMed  CAS  Google Scholar 

  22. Gutterman JU, McBride C, Fredrick EJ, et al (1973) Active immunotherapy with BCG for recurrent malignant melanoma. Lancet i: 1208

    Article  Google Scholar 

  23. Terry WD (1980) Immunotherapy of malignant melanoma. N Engl J Med 303: 1174

    Article  PubMed  CAS  Google Scholar 

  24. Silber HKB, Salinas FA, Kong S (1986) Interferons in cancer treatment. MES Medical Education Services, Toronto

    Google Scholar 

  25. Foon KA, Sherwin SA, Abrams PG, et al (1985) A phase I trial of recombinant gamma interferon in patients with cancer. Cancer Immunol Immunother 20: 193

    Article  PubMed  CAS  Google Scholar 

  26. Creagan ET, Ahmann DL, Frytak S, et al (1987)Three consecutive phase-II-studies of recombinant interferon alpha-2a in advanced malignant melanoma. Cancer 59:638

    Article  PubMed  CAS  Google Scholar 

  27. Ettinghausen SE, Rosenberg SA (1986)The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin 2. Springer Semin Immunopathol 9: 51

    Article  PubMed  CAS  Google Scholar 

  28. Balch CM, Milton GW, Shaw HM, et al (1985) Cutaneous melanoma, clinical management and treatment results worldwide. Lippincott, Philadelphia

    Google Scholar 

  29. Bellet RE, Mastrangelo MJ, et al (1979) Chemotherapy of metastatic melanoma. In: Clark WH (ed) Human malignant melanoma. Crune & Stratton, New York, p 325

    Google Scholar 

  30. Voigt H, Caselitz J,Jänner M (1981)Veno-occlusives Syndrom mit akuter Leberdystrophie unter Dacarbazin-Therapie eines malignen Melanoms. Klin Wochenschr 69: 229

    Article  Google Scholar 

  31. Overgaard J (1986) The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 12: 867

    Article  PubMed  CAS  Google Scholar 

  32. Rigel DS, Kopf AW, Friedman RJ (1987) The rate malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 17: 1050

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag/Wien

About this paper

Cite this paper

Fritsch, P., Pichler, E. (1990). Klinik, Differentialdiagnose und Therapie des Melanoms. In: Prostatakarzinom Malignes Melanom Bildgebende Verfahren in der Onkologie. Angewandte Onkologie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9107-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9107-1_2

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82228-9

  • Online ISBN: 978-3-7091-9107-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics